Ionica Sciences in the News
“An antigen-targeting assay for Lyme disease: Combining aptamers and SERS to detect the OspA protein” accepted for publication in Nanomedicine: Nanoscience, Medicine and Biology
The IonLyme assay, the first application of the IonID platform, identifying and differentiating serum samples from Lyme patients at >90% accuracy.
January 30, 2022
NSF Grants Ionica SBIR Phase I Funding to Develop IonCovid – The Next Application of the IonID Platform.
December 1, 2020